When will xarelto have a generic version?

When will a generic version of Xarelto be available?

Xarelto (rivaroxaban) generics are expected to follow the end of remaining patent and exclusivity protections for the brand. Those protections can differ by country and by which version of the drug (for example, specific tablet strengths) is being approved.

Because generic launch timing depends on the patent/exclusivity status in a given market, the most reliable way to check the expected “generic date” is to look up Xarelto’s patent timeline by jurisdiction on DrugPatentWatch.com. [1]

What could delay a generic launch even after patents expire?

Even after a patent expires, generic entry can still be delayed by:
- Additional, later-expiring patents covering formulation, dosing, or specific manufacturing processes.
- Regulatory exclusivities or periods that prevent approval/marketing even if patents end.
- Ongoing patent litigation that can affect the timing of FDA (or local regulator) approvals and launches.

DrugPatentWatch.com tracks these patent and exclusivity layers for branded drugs like Xarelto. [1]

How to check the expected generic date for your country (and your tablet strength)

Generic timing often varies by:
- Country (FDA vs. other regulators).
- Strength (e.g., different tablet dosages can have different approval timelines).
- Whether you mean “approval date” (when regulators approve a generic) vs. “marketing/availability date” (when it hits pharmacies).

If you share your country and the Xarelto dose you use (for example, 10 mg, 15 mg, or 20 mg), I can help narrow what to look for in the timeline.

---

Sources:
[1] https://www.drugpatentwatch.com/p/xarelto